208 related articles for article (PubMed ID: 37379314)
1. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
[TBL] [Abstract][Full Text] [Related]
2. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
3. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
4. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection.
Lodi S; Klein M; Rauch A; Epstein R; Wittkop L; Logan R; Rentsch CT; Justice AC; Touloumi G; Berenguer J; Jarrin I; Egger M; Puoti M; D'Arminio Monforte A; Gill J; Salmon Ceron D; van Sighem A; Linas B; van der Valk M; Hernán MA;
J Int AIDS Soc; 2022 Dec; 25(12):e26048. PubMed ID: 36562643
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
Hanna J; Sufian J; Suh JS; Jimenez HR
HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
[TBL] [Abstract][Full Text] [Related]
6. [Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection].
Łucejko M; Grzeszczuk A; Jaroszewicz J; Flisiak R
Pol Merkur Lekarski; 2013 Aug; 35(206):72-6. PubMed ID: 24052984
[TBL] [Abstract][Full Text] [Related]
7. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
[TBL] [Abstract][Full Text] [Related]
8. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
[TBL] [Abstract][Full Text] [Related]
9. Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.
Brooks R; Wegener M; Speers S; Nichols L; Sideleau R; Valeriano T; Buchelli M; Villanueva M
Health Promot Pract; 2023 Sep; 24(5):1039-1049. PubMed ID: 37439600
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences.
Fursa O; Mocroft A; Lazarus JV; Amele S; Lundgren J; Matulionyte R; Rasmussen LD; Rockstroh JK; Parczewski M; Jilich D; Moreno S; Vassilenko A; Lacombe K; Wandeler G; Borodulina E; Brännström J; Wiese L; Orkin C; Behrens GMN; Mansinho K; Portu JJ; Peters L;
AIDS; 2022 Mar; 36(3):423-435. PubMed ID: 34690281
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
Ryscavage P; Hussien S; Seung H; Hynicka L
HIV Med; 2024 May; 25(5):622-627. PubMed ID: 38273652
[TBL] [Abstract][Full Text] [Related]
12. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
Berenguer J; Gil-Martin Á; Jarrin I; Montes ML; Domínguez L; Aldámiz-Echevarría T; Téllez MJ; Santos I; Troya J; Losa JE; Serrano R; De Guzmán MT; Calvo MJ; González-García JJ;
AIDS; 2019 Mar; 33(4):685-689. PubMed ID: 30829744
[TBL] [Abstract][Full Text] [Related]
13. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.
Simmons B; Saleem J; Hill A; Riley RD; Cooke GS
Clin Infect Dis; 2016 Mar; 62(6):683-694. PubMed ID: 26787172
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort.
Fursa O; Reekie J; Kuzin I; Hetman L; Kryshchuk A; Starychenko O; Hrytsaiuk N; Khodus I; Nyzhnyk A; Rakhuba V; Kovalevska M; Maistat T; Pryhoda I; Ahieieva M; Varvarovska O; Valdenmaiier O; Lundgren J; Peters L;
J Int AIDS Soc; 2023 Sep; 26(9):e26166. PubMed ID: 37705358
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018.
Simoncini GM; Hou Q; Carlson K; Buchacz K; Tedaldi E; Palella F; Durham M; Li J;
AIDS Patient Care STDS; 2021 Oct; 35(10):392-400. PubMed ID: 34623891
[TBL] [Abstract][Full Text] [Related]
16. Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Sun HY; Liu WD; Wang CW; Wei YJ; Lin KY; Huang YS; Su LH; Chen YT; Liu WC; Su YC; Chen YW; Chuang YC; Lu PL; Hung CC; Yu ML
Microbiol Spectr; 2022 Jun; 10(3):e0034522. PubMed ID: 35579445
[TBL] [Abstract][Full Text] [Related]
17. The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study.
Kurniawan J; Gani RA; Djauzi S; Ibrahim F; Harimurti K; Nafrialdi N; Imannuel S
Acta Med Indones; 2019 Apr; 51(2):128-136. PubMed ID: 31383827
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
[TBL] [Abstract][Full Text] [Related]
19. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
20. Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Kronfli N; Young J; Wang S; Cox J; Walmsley S; Hull M; Cooper C; Martel-Laferriere V; Wong A; Pick N; Klein MB;
Clin Infect Dis; 2021 Aug; 73(3):468-477. PubMed ID: 32504083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]